Substance P Drives Organ Damage in Acute Pancreatitis by Promoting Immune Cell Infiltration

Substance P promoted leukocyte infiltration into the liver and lungs during acute pancreatitis in mice, revealing a neuropeptide mechanism driving multi-organ failure in this deadly condition.

Zhu, Zhixing et al.·International journal of molecular sciences·2024·Moderate Evidenceanimal study
RPEP-09696Animal studyModerate Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
animal study
Evidence
Moderate Evidence
Sample
N=not reported
Participants
Sepsis mouse models analyzing SP/NK1R-mediated adhesion molecule expression and leukocyte infiltration

What This Study Found

Substance P promoted leukocyte infiltration into liver and lungs during acute pancreatitis in mice, revealing a neuropeptide-mediated mechanism for multi-organ damage.

Key Numbers

SP upregulated both ICAM1 and VCAM1 on vascular endothelial cells in the liver and lungs, promoting leukocyte infiltration.

How They Did This

Mouse model of acute pancreatitis. Assessed Substance P levels, NK1R signaling, leukocyte infiltration in liver and lungs, organ damage markers, and inflammation.

Why This Research Matters

Acute pancreatitis kills thousands annually from organ failure, and there is no specific treatment to prevent multi-organ damage. Identifying Substance P as a driver of distant organ injury reveals a druggable target — NK1R blockers like aprepitant are already available.

The Bigger Picture

Substance P is increasingly recognized as a systemic inflammatory amplifier beyond its pain-signaling role. This study places it at the center of pancreatitis-induced organ failure, joining a growing body of evidence that neuropeptide signaling drives inflammatory organ damage across many diseases.

What This Study Doesn't Tell Us

Mouse pancreatitis model may not fully replicate human disease severity. The contribution of Substance P relative to other inflammatory mediators is unclear. Clinical translation requires testing NK1R blockade in pancreatitis patients.

Questions This Raises

  • ?Could aprepitant (NK1R blocker) prevent organ failure in severe human pancreatitis?
  • ?Is Substance P a biomarker for predicting multi-organ failure in pancreatitis patients?
  • ?Do other neuropeptides contribute to pancreatitis-associated organ damage?

Trust & Context

Key Stat:
Neuropeptide drives organ failure Substance P promotes immune cell infiltration into liver and lungs during pancreatitis, revealing a targetable mechanism for preventing multi-organ damage
Evidence Grade:
Preliminary evidence: mouse pancreatitis study with clear mechanistic findings. NK1R blockers exist but have not been tested in pancreatitis patients.
Study Age:
Published in 2024. Connects neuropeptide signaling to a major cause of intensive care mortality.
Original Title:
Substance P Promotes Leukocyte Infiltration in the Liver and Lungs of Mice with Sepsis: A Key Role for Adhesion Molecules on Vascular Endothelial Cells.
Published In:
International journal of molecular sciences, 25(12) (2024)
Database ID:
RPEP-09696

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

How does Substance P cause organ damage?

During acute pancreatitis, Substance P activates NK1R receptors that signal immune cells to flood the liver and lungs. This immune cell infiltration damages these organs, potentially causing the deadly multi-organ failure seen in severe pancreatitis.

Could blocking Substance P save lives in pancreatitis?

This study suggests yes — blocking the SP/NK1R pathway could prevent the immune cell infiltration that causes organ failure. Aprepitant (an NK1R blocker already used for nausea) could potentially be repurposed for this, but human trials are needed.

Read More on RethinkPeptides

Cite This Study

RPEP-09696·https://rethinkpeptides.com/research/RPEP-09696

APA

Zhu, Zhixing; Chambers, Stephen; Bhatia, Madhav. (2024). Substance P Promotes Leukocyte Infiltration in the Liver and Lungs of Mice with Sepsis: A Key Role for Adhesion Molecules on Vascular Endothelial Cells.. International journal of molecular sciences, 25(12). https://doi.org/10.3390/ijms25126500

MLA

Zhu, Zhixing, et al. "Substance P Promotes Leukocyte Infiltration in the Liver and Lungs of Mice with Sepsis: A Key Role for Adhesion Molecules on Vascular Endothelial Cells.." International journal of molecular sciences, 2024. https://doi.org/10.3390/ijms25126500

RethinkPeptides

RethinkPeptides Research Database. "Substance P Promotes Leukocyte Infiltration in the Liver and..." RPEP-09696. Retrieved from https://rethinkpeptides.com/research/zhu-2024-substance-p-promotes-leukocyte

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.